Thomas Scientific

A potential metabolite of 8-iso PGF2&beta via the 15-hydroxy PGDH pathway.

A major urinary metabolite of PGE2 that is excreted in guinea pig urine at a concentration range of 1.34-2.74.

A hepatic metabolite of zearalenone that is a less potent agonist of estrogen receptors than the parent compound.

A major urinary metabolite of PGE2 that is excreted in guinea pig urine at a concentration range of 1.34-2.74.

8-iso PGF1&beta is a potential autoxidation product of DGLA. There are no published reports on its isolation from any biological source or on its biological activity.

An isomer of Vitamin E that has less potent antioxidant properties than &alpha-tocotrienol.

A derivative of PGF2&beta with increased water solubility.

9&beta-hydroxy stereoisomer of PGF2&alpha much less active than PGF2&alpha in antifertility and bronchoconstrictor activities exhibits bronchodilating activity in guinea pigs and cats and antagonizes the bronchoconstrictor activity of

16,16-dimethyl PGF2&beta is a metabolically stable analog of PGF2&beta. It prevents bronchospasm in asthmatics but is less potent than PGE2.

8-iso PGF2&beta is an isomer of PGF2&alpha with a non-enzymatic, non-cyclooxygenase origin. It is one of 64 possible isomers of PGF2&alpha which can be produced by free radical peroxidation of arachidonic acid.

A hepatic metabolite of zearalenone that is a less potent agonist of estrogen receptors than the parent compound.

PGF1&beta is the C-9 epimer of PGF1&alpha. It was shown to enhance respiratory rate in experimental animals when administered intravenously.